http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-583031-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0072
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20
filingDate 2008-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45844bbed086832a7dddabff77e8f040
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbd0962330bb044c75fdd6fd82664d77
publicationDate 2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-583031-A
titleOfInvention Tunably crosslinked hyaluronic acid compositions
abstract A process for the preparation of crosslinked hyaluronic acid hydrogel suitable for soft tissue augmentation is disclosed, wherein said process comprises:(a) hydrating sodium hyaluronate fibers in a sodium hydroxide solution to produce hydrated sodium hyaluronate fibers; and (b) contacting the sodium hyaluronate fibers with a polyethylene glycol-based epoxide crosslinking agent to create a crosslinked hyaluronic acid hydrogel suitable for soft tissue augmentation, wherein the polyethylene glycol-based epoxide crosslinking agent has two to six reactive groups for linking to hyaluronic acid side chains, preferably the polyethylene glycol-based epoxide crosslinking agent is tetrafunctional.
priorityDate 2007-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HKM3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9U6V9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410789385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450365498
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ3S820
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530626
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCW0HFN9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID174383
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB3EWP2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID406146
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54699
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15316
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CH89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ08169
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17046
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26831
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI0CME8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86687
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCR4J7Z9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3QVN6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582758
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49371
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI0CME7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3QVN2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424968158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914

Total number of triples: 53.